Eli Lilly and Company Recalls Lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar


Pharmaceutical Recall Related Images

meta herbal magnum xxl 9800 packaging
medline bed assist bar
Senna Syrup
Glucagon Emergency Kit for Low Blood Sugar front of packaging
Glucagon Emergency Kit for Low Blood Sugar front of packaging

Eli Lilly and Company (NYSE: LLY) is voluntarily recalling lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar (Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe), to the consumer/user level. Lilly is recalling lot D239382D to the patient level because of a product complaint reporting that the vial of Glucagon was in liquid form instead of the powder form. The firm’s investigation indicates that the liquid in this Glucagon vial could be related to the manufacturing process. The use of the liquid form of this product may fail to treat severe low blood sugar due to loss of potency.

Risk Statement: Severe hypoglycemia in patients with diabetes, if not reversed, can potentially cause adverse health consequences ranging from transient, minor complaints to neurological damage, seizures, and even death if not promptly treated. Associated with the one product complaint, it was reported to Lilly that the involved patient experienced lack of drug effect and also reported subsequent seizures.

Glucagon Emergency Kit is used as an anti-hypoglycemic agent and a gastrointestinal motility inhibitor indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus.

The product is packaged in a kit containing 1mg of freeze-dried (lyophilized) product in a 3 mL vial and a pre-filled diluent syringe. The affected Glucagon Emergency Kit lot is D239382D and the expiration date is April 2022 (label expiry date: 04 2022). The lot number can be found on the label of the kit as well as the vial. The lot was distributed nationwide to wholesalers and retailers.

Lilly is deeply committed to manufacturing high-quality medicines for patients who need them, and the safety and quality of our products is our highest priority. We take our obligations seriously and have rigorous quality systems in place to ensure compliance with stringent regulatory requirements.

Lilly is notifying its distributors and customers by written communication and is arranging for return and replacement of all recalled products. Wholesalers and Distributors with an existing inventory of Glucagon Emergency Kit lot D239382D should cease distribution and quarantine the product immediately.

Instructions for Wholesalers and Pharmacists

If you have distributed the recalled product, please notify any accounts or additional locations which may have received product from the recalled lot from you. Please conduct a sub-recall to those accounts and communicate this recall information immediately. Please request they immediately cease distribution of the product and promptly contact Sedgwick at 877-907-7032 (Interactive Voice Recording), 877-884-9410 (Fax), or elililly7484@sedgwick.com (Mon.-Fri. 8:00 am - 5:00 pm ET) to obtain a Business Reply Card (BRC) to initiate the return process.

Glucagon Emergency Kit inside of packaging
Glucagon Emergency Kit inside of packaging

Instructions for Consumers

Consumers in possession of Glucagon Emergency Kit lot D239382D should contact The Lilly Answers Center at 1-800-LILLYRX (1-800-545-5979) for return and replacement instructions for the product (hours of operation are Monday- Friday, 9AM – 7PM EST) and should contact their health care provider for guidance. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

More product photos at FDA.gov

Original recall and updates at FDA.gov


Related Posts

medical recall
Suntegrity Skincare Recalls Suntegrity Impeccable Skin Sunscreen Foundation
Suntegrity Skincare Recalls Suntegrity Impeccable Skin Sunscreen Foundation
penn herb company nature’s wonderland thyroid formula
Penn Herb Company Ltd Recalls Nature’s Wonderland Thyroid Formula
Penn Herb Company Ltd Recalls Nature’s Wonderland Thyroid Formula
medical recall
Integrity Products Recalls Ram It & To The Moon Capsules
Integrity Products Recalls Ram It & To The Moon Capsules
medline bed assist bar
Medline Industries Recalls 1.5 Million Adult Portable Bed Rails – Two Deaths Reported
Medline Industries Recalls 1.5 Million Adult Portable Bed Rails - Two Deaths Reported

Latest Posts

aahu barah logo
AAHU BARAH USA INC. Recalls 19 Boxes of Aahu Barah Apricot Roll
villa nueva interservices arepa de choclo
Villa Nueva Interservices LLC. Recalls “Arepas LA Mejor” 25 oz bags of Arepa de Choclo
medical recall
Suntegrity Skincare Recalls Suntegrity Impeccable Skin Sunscreen Foundation
penn herb company nature’s wonderland thyroid formula
Penn Herb Company Ltd Recalls Nature’s Wonderland Thyroid Formula
bambu lab a1 printer
Bambu Lab Recalls A1 3D Printers Due to Electric Shock and Fire Hazards

Leave a Reply

Your email address will not be published. Required fields are marked *

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.